Abrogation of mitochondrial transcription in smooth muscle cells impairs smooth muscle contractility and vascular tone

Journal of Physiology and Pharmacology

Volumn 59, Issue 2, 2008, Pages 239-252

  Jawien, J ^a,b   Bian, Z ^a   Sheikine, Y ^a,b   Olofsson, P S ^a   Pang, Y ^a   Edholm, T ^a   Dou, Y ^a   Metzger, D ^c   Hellstrom P M ^a   Feil, R ^d   Hansson, Göran K ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cre loxP; Haemodynamics; Mitochondria; Oxidative phosphorylation; Smooth muscle cells; Tfam

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; TAMOXIFEN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; BLOOD PRESSURE MONITORING; BLOOD VESSEL TONE; CATABOLISM; CONTROLLED STUDY; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GLYCOLYSIS; HEART RATE; IN VIVO STUDY; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; STOMACH FUNDUS; STOMACH MUSCLE; TFAM GENE;

ANIMALS; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; TRANSCRIPTION, GENETIC; VASOCONSTRICTION;

EID: 46849083933     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Somlyo AP, Somlyo AV. Vascular smooth muscle. I. Normal structure, pathology, biochemistry, and biophysics. Pharmacol Rev 1968; 20: 197-272.
2. Paul RJ, Bauer M, Pease W. Vascular smooth muscle: Aerobic glycolysis linked to sodium and potassium transport processes. Science 1979; 206: 1414-1416.
3. Paul RJ. Functional compartmentalization of oxidative and glycolytic metabolism in vascular smooth muscle. Am J Physiol 1983; 244: C399-409.
4. Graff C, Clayton DA, Larsson NG: Mitochondrial medicine - recent advances. J Intern Med 1999; 246: 11-23.
5. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283: 1482-1488.
6. Larsson NG, Wang J, Wilhelmsson H et al. Mitochondrial transcription factor a is necessary for mtdna maintenance and embryogenesis in mice. Nat. Genet 1998; 18: 231-236.
7. Wang J, Wilhelmsson H, Graff C et al. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 1999; 21: 133-137.
8. Wredenberg A, Wibom R, Wilhelmsson H et al. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci U S A 2002; 99: 15066-15071.
9. Kuhbandner S, Brummer S, Metzger D, Chambon P, Hofmann F, Feil R. Temporally controlled somatic mutagenesis in smooth muscle. Genesis 2000; 28: 15-22.
10. Akagi K, Sandig V, Vooijs M et al. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res 1997; 25: 1766-1773.
11. Edholm T, Levin F, Hellstrom PM, Schmidt PT: Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept 2004; 121: 25-30.
12. Collins KA, Korcarz CE, Lang RM. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiol Genomics 2003;13:227-239.
13. Bian Z, Yan ZQ, Hansson GK, Thoren P, Normark S. Activation of inducible nitric oxide synthase/nitric oxide by curli fibers leads to a fall in blood pressure during systemic escherichia coli infection in mice. J Infect Dis 2001; 183: 612-619.
14. Clement JG, Mills P, Brockway B: Use of telemetry to record body temperature and activity in mice. J Pharmacol Methods 1989; 21: 129-140.
15. Kramer K, van Acker SA, Voss HP, Grimbergen JA, van der Vijgh WJ, Bast A. Use of telemetry to record electrocardiogram and heart rate in freely moving mice. J Pharmacol Toxicol Methods 1993; 30: 209-215.
16. Zhu Y, Bian Z, Lu P et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002; 295: 505-508.
17. Ignarro L, Byrns R, Wood K. Pharmacological and biochemical properties of endothelium-derived relaxant factor (edrf): Evidence that edrf is closely related to nitric oxide (no) radical. Circulation 1986; 74: 287.
18. Moncada S, Higgs A: The 1-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
19. Webb RC. Smooth muscle contraction and relaxation. Adv Physiol Educ 2003; 27: 201-206.
20. Kristek F, Koprdová R, Cebová M. Long-term effects of early administered sildenafil and NO donor on the cardiovascular system of SHR. J Physiol Pharmacol 2007; 58: 33-43.
21. Gonzáles-Luis G, Fletcher AJ, Moreno L, Pérez- Vizcaíno F, Blanco CE, Villamor E. Nitric oxide-mediated nonadrenergic noncholinergic relaxation of piglet pulmonary arteries decreases with postnatal age. J Physiol Pharmacol 2007; 58: 45-56.
22. Pires W, Wanner SP, La Guardia RB, Rodrigues LO, Silveira SA, Coimbra CC, Marubayashi U, Lima NR. Intracerebroventricular physostigmine enhances blood pressure and heat loss in running rats. J Physiol Pharmacol 2007; 58: 3-17.
23. Ramachandran A, Levonen AL, Brookes PS et al. Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radic Biol Med 2002; 33: 1465-1474.